Creo Medical Group PLC
LSE:CREO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.55
19.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
CREO Price Targets Summary
Creo Medical Group PLC
According to Wall Street analysts, the average 1-year price target for
CREO
is 40.8 GBX
with a low forecast of 40.4 GBX and a high forecast of 42 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CREO's stock price target?
Price Target
40.8
GBX
According to Wall Street analysts, the average 1-year price target for
CREO
is 40.8 GBX
with a low forecast of 40.4 GBX and a high forecast of 42 GBX.
What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
69%
The
compound annual growth rate
of Creo Medical Group PLC's revenue for the next 4 years is
69%.
